Asia-Pacific In-Vitro Fertilization Market, By Product Type (Devices, Reagents, Services, and Pharmaceuticals), By End Users (Fertility Clinics, Hospitals, Clinical Research Centers, and Cryobanks), By Procedure (Fresh Donor, Fresh Nondonor, Frozen Donor, and Frozen Nondonor) and By Country (China, India, Japan, South Korea, and Rest of Asia Pacific) - Trends, Analysis and Forecast till 2034

Asia-Pacific In-Vitro Fertilization Market was valued at US$ 0.6 billion in 2024 and is projected to grow at a CAGR of 18.7% to reach US$ 2.9 billion by 2034.

In Vitro Fertilization (IVF) is a popular reproductive procedure that involves removing ova from a woman's ovaries and manually dispersing a sample of male sperm in a lab glass dish. These fertilized eggs are then transferred to the same or another female's uterus for embryo development for a few days to establish a successful pregnancy.

Growing rates of infertility worldwide, coupled with rising awareness of infertility among the global population and the availability of treatment, are driving growth of the Asia-Pacific in-vitro fertilization market. Infertility affects about 17.5% of adult people globally, or 1 in 6 of them, according to a World Health Organization (WHO) report from 2023. This indicates the urgent need to expand access to high-quality, reasonably priced reproductive care for individuals who require it. The target market is increasing as a result of rising male infertility rates as well as the growing median age of first-time mothers. Throughout the projection period, increasing cigarette and alcohol use is also anticipated to support target market expansion. One of the main elements driving the target market's growth is the steps the Asia-Pacific region governments are taking to encourage IVF procedures.

In the near future, the Asia-Pacific in-vitro fertilization market is anticipated to expand more slowly due to the high cost of the IVF procedure. Additionally, the target market's growth will soon be hampered by the poor success rate of IVF treatments. Furthermore, the target market is anticipated to have profitable growth potential as a result of major companies in the industry introducing cutting-edge products for this therapy.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Asia-Pacific In-Vitro Fertilization Market Key Drivers:

Late pregnancies among women

• The fourth decade of a woman's life marks a significant fall in her ability to procreate, closely linked to a decline in oocyte quality and quantity associated with aging. Fecundity declines progressively after the age of 32 and quickly after the age of 38. Oocyte quality is probably the main factor driving a decline in fertility with age since the frequency of live births after oocyte donation in older women is proportionate to the donor's age.
• This may increase the likelihood of genetic problems in the egg as well as pregnancy difficulties like stillbirths, miscarriages, and premature deliveries, among other health issues. Therefore, it is anticipated that a rise in the tendency of late pregnancies among women in the upcoming years will drive the Asia-Pacific In-Vitro Fertilisation market.
• In addition, the Asia-Pacific region is seeing a sharp increase in the number of fertility clinics due to advances in IVF treatment knowledge, low cost of IVF treatments, and technological advancements like testicular sperm extraction techniques that help address issues with low fertility, spontaneous abortions, and low embryonic quality.

Asia-Pacific In-Vitro Fertilization Market Restrains:

The high price of ART technologies and associated complications

• The high cost of assisted reproductive technologies (ART), such as in-vitro fertilization, which is used to treat infertility, and the general lack of knowledge about available treatments are impeding the market's growth. Furthermore, the expense of infertility treatments is typically not reimbursed by insurance providers. Infertility is not regarded as a severe health issue, so it is not covered by general insurance.
• Complications from IVF treatment, which could lead to multiple pregnancies or congenital disabilities, are another significant factor impeding the growth of the IVF market in this region. Additionally, most people in some of this region's developing nations cannot afford the high costs associated with IVF procedures and limited public knowledge of the procedure, impeding the expansion of the in-vitro fertilization industry.

Asia-Pacific In-Vitro Fertilization Market Opportunities:

Technological advancements                     

• As IVF becomes more widely used, a significant share of the human population's reproductive patterns will shift. IVF will probably conceive up to 10% of all children in the near future in several different parts of the world. It is now clear that the development of the required instruments, the accumulation of experience and training among those carrying out the procedure, and technological advancement have all contributed to success rates rising to as much as 56%, providing a promising indication of the market's growth over the forecast period.

Asia-Pacific In-Vitro Fertilization Market is segmented based on Product Type, End Users, Procedure and Country:

Product Type Insights:

• Devices:

The devices are specialized equipment used for collecting the egg, removing sperm, cryopreservation, and manipulating the embryo. They offer efficient execution of treatment procedures without harming the gametes.

• Reagents:

Reagents are special chemicals and culture media used in various stages of the in-vitro fertilization process. The reagents and media offer favorable environmental conditions for the egg and the sperm.

• Services:

Services include those offered by specialists in the IVF process. This includes clinicians, nurses, embryologists, and lab technicians. They take on several roles in handling the IVF procedure at various stages.

• Pharmaceuticals:

Doctors provide fertility drugs for the patients, which stimulate the release of ovum and hormonal supplements to regulate hormones in the body.

Among the segments mentioned above, the one that dominated the market is the Services segment, as the IVF professionals and nurses provide a complete package, which is usually opted by the patients, including consultancy services, tests, procedures, and post-IVF care.

End Users Insights:

• Fertility Clinics:

Fertility clinics offer specialized treatment facilities for IVF procedures and other assisted reproductive technologies (ART). They are equipped with equipment, necessary reagents, drugs, and professionals in the field.

• Hospitals:

Hospitals contain a section for IVF services along with other departments. They invest in collaboration with doctors and fertility clinics to provide these services.

• Clinical Research Centers:

Clinical research centers are crucial in developing new and advanced IVF techniques and procedures. They monitor and govern the clinics and hospitals.

• Cryobanks:

Cryobanks are an integral part of the IVF process. they provide supply and storage facilities for the hospitals and fertility clinics. Their primary role is to store frozen eggs, sperm, and embryos for future use in IVF procedures.

Among the segments mentioned above, the one that dominated the market is the Fertility Clinics segment due to their widespread adoption of advanced devices, personalized care, and seamless integration of improved fertility treatments.

Procedure Insights:

• Fresh Donor:

Fresh donor involves the use of sperm and egg from heathy donors. This procedure is usually opted by couples with fertility issues with their own gametes.

• Fresh Nondonor:

In Fresh Nondonors, the eggs and sperms of the couples are used for fertilization. Donors' gametes are not involved in this cycle.  

• Frozen Donor:

In this procedure, frozen gametes, eggs, and sperms from donors are used for IVF cycles when fresh samples are unavailable.

• Frozen Nondonor:

The couples undergoing the IVF procedure cryopreserve their gametes, which are then used for further IVF cycles after a fresh cycle is completed successfully.

Among the segments mentioned above, the one that dominated the market is the Fresh Nondonor segment because of its higher success rate than the other cycles, better birth rates compared to frozen embryos, and easy-to-implement mechanism. 

Country Insights:

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Asia-Pacific In-Vitro Fertilization Market Country Insights

• China's market is estimated to witness a significantly large revenue share over the forecast period due to rising rates of infertility and profitable increases in fertility tourism, as well as more significant government restrictions and disposable income. Furthermore, the fast expansion of China's IVF market is fueled by rising healthcare expenditures, technological improvements, and increased R&D efforts.
• The Indian market is estimated to witness the fastest revenue share because the availability of qualified professionals, rising rates of infertility, a rapidly aging population, and expanding government initiatives to support IVF in India are propelling the market in this region.
• Japan's market finds lucrative opportunities owing to the growing awareness of infertility and readily accessible treatment choices, as well as the emergence of technical innovation in healthcare, IVF, laboratory procedures, cryopreservation, and genetic screening.
• The South Korean market is increasing gradually due to the increased patient-centric and individualized treatment solutions awareness, a growing focus on fertility treatments and alternatives, and an increase in the prevalence of infertility difficulties brought on by changing lifestyles.
• The rest of Asia Pacific market is an emerging market due to government expenditures in research and development, an increase in medical tourism, and a growth in the number of IVF clinics across several nations.

Report Scope:                       

Attribute	Details
Market Size 2024	US$ 0.6 billion
Projected Market Size 2034	US$ 2.9 billion
CAGR Growth Rate	18.7%
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Product Type - Devices, Reagents, Services, and Pharmaceuticals. By End Users - Fertility Clinics, Hospitals, Clinical Research Centers, and Cryobanks.  By Procedure - Fresh Donor, Fresh Nondonor, Frozen Donor, and Frozen Nondonor.
Regional scope	Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and analyzes the latest industry trends and opportunities in each sub-segments from 2024 to 2034. For the purpose of this study segmented the Asia-Pacific In-Vitro Fertilization Market report based on Product Type, End Users, Procedure and region:

Asia-Pacific In-Vitro Fertilization Market, By Product Type:

• Devices
• Reagents
• Services
• Pharmaceuticals

Asia-Pacific In-Vitro Fertilization Market, By End Users:

• Fertility Clinics
• Hospitals
• Clinical Research Centers
• Cryobanks

Asia-Pacific In-Vitro Fertilization Market, By Procedures:

• Fresh Donor
• Fresh Nondonor
• Frozen Donor
• Frozen Nondonor

 Asia-Pacific In-Vitro Fertilization Market, By Country:

• China
• India
• Japan
• South Korea
• Rest of Asia Pacific

The key players operating the Asia-Pacific In-Vitro Fertilization Market include Adorefem Gynec Pro-Infertility Division, Cook Medical, Esco Group of Companies, Ferring Pharmaceuticals, FUJIFILM Irvine Scientific, Hunter Scientific Limited, IVFtech ApS, Labotect Labor-Technik-Göttingen GmbH, Merck KGaA, and Olympus Corporation.

• In July 2022, FUJIFILM Irvine Scientific, Inc., a global leader in the innovation, development, and manufacturing of cell culture media and assisted reproductive technologies (ART), revealed the release of Heavy Oil for Embryo Culture, a sterile mineral oil with an optimal weight viscosity that strikes the perfect balance between ease of use and optimal protection for the IVF laboratory.

• Adorefem Gynec Pro-Infertility Division*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Cook Medical
• Esco Group of Companies
• Ferring Pharmaceuticals
• FUJIFILM Irvine Scientific
• Hunter Scientific Limited
• IVFtech ApS
• Labotect Labor-Technik-Göttingen GmbH
• Merck KGaA
• Olympus Corporation

 "*" marked represents similar segmentation in other categories in the respective section.

Research Objective and Assumption

• Preface
• Research Objectives
• Study Scope
• Years Considered for the study
• Assumptions
• Abbreviations

Research Methodology

• Research data
• Primary Data
  • Primary Interviews
  • Primary Breakdown
  • Key data from Primary Product Types
  • Key Thickness Insights
• Secondary Data
  • Major Secondary Product Types
  • Secondary Product Types
• Market Estimation
• Top-Down Approach
  • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
• Bottom-Up Approach
  • Approach for estimating market share by Bottom-up Analysis (Demand Side)
• Market Breakdown and Data Triangulation
• Research Assumptions

Market Preview

• Executive Summary
• Key Findings—Global Outlook for medical carts Strategies
  • Key Questions this Study will Answer
  • Market Snippet, By Product Type
  • Market Snippet, By End Users
  • Market Snippet, By PROCEDURE
  • Market Snippet, By Region
• Opportunity Map Analysis
• Executive Summary—3 Big Predictions

Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restrains
  • Market Opportunities
  • Market Trends
• DR Impact Analysis
• PEST Analysis
• Porter’s Five Forces Analysis
• Opportunity Orbit
• Market Investment Feasibility Index
• Macroeconomic Factor Analysis

Market Segmentation, By Product Type, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Devices
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Reagents
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Services
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Pharmaceuticals
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By End Users, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Fertility Clinics
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Hospitals
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Clinical Research Centers
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Cryobanks
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By PROCEDURE, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Fresh Donor
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Fresh Nondonor
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Frozen Donor
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Frozen Nondonor
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Region Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End Users, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By PROCEDURE, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • U.S.
    • Canada
• Europe
  • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End Users, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By PROCEDURE, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • UK
    • France
    • Germany
    • Russia
    • Italy
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End Users, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By PROCEDURE, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific
• Latin America
  • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End Users, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By PROCEDURE, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
  • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End Users, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By PROCEDURE, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• GCC
• Israel
• South Africa
• Rest of Middle East

Competitive Landscape

• Heat Map Analysis
• Market Presence and Specificity Analysis

Company Profiles

• Esco Group of Companies
  • Company Overview
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Ferring Pharmaceuticals
  • Company Overview
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• FUJIFILM Irvine Scientific
  • Company Overview
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Hunter Scientific Limited
  • Company Overview
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• IVFtech ApS
  • Company Overview
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Labotect Labor-Technik-Göttingen GmbH
  • Company Overview
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Merck KGaA
  • Company Overview
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Olympus Corporation
  • Company Overview
  • Product Type Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

The Last Word

• Future Impact
• About Us
• Contact